Share or Print this page

We are pleased to present our 2023 Year in Review, showcasing the important progress we’ve made in the fight against Alzheimer’s disease over the last year right here in Massachusetts and New Hampshire. Our staff, community partners, volunteers, and public policy advocates have worked tirelessly to support the 156,000 individuals living with this disease across our two states.

We are pleased to present our 2023 Year in Review, showcasing the important progress we’ve made in the fight against Alzheimer’s disease and all other dementia. Our staff, board members, community partners, volunteers, and public policy advocates have worked tirelessly to support the 156,000 individuals living with this disease across our two states.

Earlier this year, we witnessed the beginning of a new era in the fight against Alzheimer’s disease—the era of treatment. Lecanemab, marketed as Leqembi, received full FDA approval after posting impressive results in an effort to slow the progression of Alzheimer’s for those in the earliest stage of the disease. The Centers for Medicare and Medicaid Services (CMS) followed this exciting approval by confirming that it will cover Leqembi, albeit with a physician registry. You can read more about our advocacy efforts that impacted this important decision in our Public Policy section.

We continue to increase the number of in-person education programs, support groups, and early-stage engagement programs we offer, while maintaining a robust virtual calendar. Over the past year, over 31,000 people accessed the full range of our programs and services, all delivered at no cost to families.

This year, our generous supporters helped us raise more than $15 million to continue funding research and care and support programs in local communities across our two states. Our advocacy efforts resulted in increased federal resources for research and caregiver support, plus local funding to expand awareness initiatives and our Dementia Care Coordination program (DCC).

We continue to expand our diversity and inclusion efforts, reaching into new communities and strengthening our volunteer base, while expanding our awareness activities into underserved communities. We are forging new partnerships with community leaders and grassroots organizations, with a focus on the Black, LatinX and Haitian communities.

We have over $23 million in active funding awarded to local researchers through our International Research Grants Program, ensuring that we will continue to have an impact on the quest for an effective treatment for this devastating disease.

All of this wouldn’t be possible without you, and we are tremendously grateful for your continued support.

Jean Morse Jones, Chair, Board of Directors
James Wessler, CEO, MA/NH Chapter and New England Regional Leader